Back to top

Voyager Therapeutics advances tau-silencing gene therapy program

Voyager Therapeutics ( ($VYGR) ) has provided an update. On July 13, 2026, Voyager Therapeutics presented three- and six-month good laboratory prac...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Voyager Therapeutics, Inc. (VYGR)